Recent OPDP enforcement letters target PR materials

11/27/2012

In a break from past practice, the FDA’s Office of Prescription Drug Promotion (OPDP) appears to be more closely scrutinizing drug companies’ public relations materials, as evidenced by two enforcement letters issued by OPDP last month citing a pitch letter and press releases. “Whether it’s a warning shot or a coincidence, it’s time for PR shops to brush up on the rules,” said Coalition for Healthcare Communication Executive Director John Kamp. Read more.

View Full Article in:

http://www.cohealthcom.org/2012/11/27/opdp-untitled-letters-on-pr-materials-surp...

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Chief Executive Officer
UCare Minnesota
Minneapolis, MN